Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests
Journal
Clinical Gastroenterology and Hepatology
Journal Volume
17
Journal Issue
7
Pages
1332-1340.e3
Date Issued
2019
Author(s)
Fann J.C.-Y.
Chuang S.-L.
Chen S.L.-S.
Yen A.M.-F.
Chiu S.Y.-H.
Hsu C.-Y.
Abstract
Background & Aims: In patients with positive results from a fecal immunochemical test (FIT), failure to receive a timely follow-up colonoscopy may be associated with higher risks of colorectal cancer (CRC) and advanced-stage CRC. We evaluated the prevalence of any CRC and advanced-stage CRC associated with delays in follow-up colonoscopies for patients with positive results from a FIT. Methods: We collected data from 39,346 patients (age, 50–69 years) who participated in the Taiwanese Nationwide Screening Program from 2004 through 2012 and had completed a colonoscopy more than 1 month after a positive result from a FIT. Risks of any CRC and advanced-stage CRC (stage III-IV) were evaluated using logistic regression models and results expressed as adjusted odds ratios (aORs) and corresponding 95% CIs. Results: In our cohort, 2003 patients received a diagnosis of any CRC and 445 patients were found to have advanced-stage disease. Compared with colonoscopy within 1–3 months (cases per 1000 patients: 50 for any CRC and 11 for advanced-stage disease), risks were significantly higher when colonoscopy was delayed by more than 6 months for any CRC (aOR, 1.31; 95% CI, 1.04–1.64; 68 cases per 1000 patients) and advanced-stage disease (aOR, 2.09; 95% CI, 1.43–3.06; 24 cases per 1000 patients). The risks continuously increased when colonoscopy was delayed by more than 12 months for any CRC (aOR, 2.17; 95% CI, 1.44–3.26; 98 cases per 1000 patients) and advanced-stage disease (aOR, 2.84; 95% CI, 1.43–5.64; 31 cases per 1000 patients). There were no significant differences for colonoscopy follow up at 3–6 months for risk of any CRC (aOR, 0.98; 95% CI, 0.86–1.12; 49 cases per 1000 patients) or advanced-stage disease (aOR, 0.95; 95% CI, 0.72–1.25; 10 cases per 1000 patients). Conclusions: In an analysis of data from the Taiwanese Nationwide Screening Program, we found that among patients with positive results from a FIT, risks of CRC and advanced-stage disease increase with time. These findings indicate the importance of timely colonoscopy after a positive result from a FIT. ? 2019 AGA Institute
SDGs
Other Subjects
adult; advanced cancer; aged; Article; cancer risk; cancer staging; clinical evaluation; cohort analysis; colonoscopy; colorectal cancer; disease association; disease course; feces analysis; female; follow up; human; immunochemistry; major clinical study; male; risk assessment; risk factor; chemistry; clinical trial; colonoscopy; colorectal tumor; feces; immunohistochemistry; incidence; mass screening; metabolism; middle aged; multicenter study; procedures; retrospective study; Taiwan; time factor; tumor marker; Aged; Biomarkers, Tumor; Colonoscopy; Colorectal Neoplasms; Feces; Female; Follow-Up Studies; Humans; Immunohistochemistry; Incidence; Male; Mass Screening; Middle Aged; Retrospective Studies; Taiwan; Time Factors
Publisher
W.B. Saunders
Type
journal article